Skip to main content
. 2012 Jun 22;61(12):2357–2366. doi: 10.1007/s00262-012-1297-2

Fig. 4.

Fig. 4

Correction of fluctuated NK and Treg cells by multiple types of treatment. After type 2 treatment, the Treg (CD4+CD25+high, lower row) in a malignant patient with downregulated NK population (CD3CD56+, upper row) (a) was overinduced to 15.8 % (b). Upon subsequent several courses of type 1 treatment, the Treg population became <3 % with >10 % NK (c)